Telehealth platform Hims & Hers said on Friday it will cut 68 employees, or about 4% of its workforce, as it adjusts to a U.S ...

Novo Nordisk (NVO) makes Ozempic, the best-known GLP-1 drug out today. And until quite recently, the Danish pharma giant ...

We came across a bullish thesis on The Cigna Group (CI) on Antonio Linares’ Substack. In this article, we will summarize the ...

(Billable Hours is Reuters' weekly report on lawyers and money. Please send tips or suggestions to ...

Seven pharmaceutical giants with a presence in New Jersey have announced billions in expansions. The timing is no surprise, ...

Novo Nordisk continues to deliver strong revenue, profit growth, and high economic profitability. Read why I rate NVO stock a ...

An inexpensive pill for treating HIV could become an alternative to injections for diabetic eye disease, a small study ...

Ozempic helped Novo Nordisk gain an early lead in the weight loss industry, but competition is nipping at the company's heels ...

Whichever way the tariff winds blow (and I've no special knowledge of that), Novo Nordisk stock remains arguably the cheapest ...

The acquisition expands Lilly’s pain pipeline with a slate of drugs targeting ion channel proteins like NaV1.7 and NaV1.8.

Denmark’s exports will grow clearly less than expected earlier, partly due to the setbacks Novo Nordisk A/S is facing in the ...

US President Donald Trump has backed away from a threat to impose 50 per cent tariffs imminently on imports from the European Union, giving more time for talks between Washington and the 27-nation ...